We demonstrated that EphA2 was co-precipitated with CD44 and was pulled down by exon10 peptide-conjugated beads, suggesting that CD44 forms a molecular complex with EphA2 through exon v10 on breast cancer cell surface. Here, EPHA2 is linked to breast carcinoma.